Free Biopharma Stock Content

$XBI $83.90 | -3.17% Pipeline Updates $CHRS +2.5% Coherus and Junshi Biosciences Announce Positive Results from Phase 3 Esophageal...

$XBI $86.65| -2.99% Pipeline Updates $GLSI -3.3% Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent...

(Last updates 7/21/22) On BPIQ.com we report when companies have been acquired and whether company assets are still in the database...

$XBI $89.32 | +0.26% Pipeline Updates $TCDA +4.9% Tricida Provides Update on Timing of Top-Line Data for the VALOR-CKD Trial Based on...

$XBI $89.09 | Pipeline Updates $FNCH Finch Therapeutics Provides an Update on its Phase 3 Trial of CP101 in Recurrent C. difficile...

$XBI $89.83 | +0.03% Covid Updates $NVAX +2.1% Novavax Announces Extended Durability of Protection Against Infection and Disease in...

As we reach the end of the month, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves...

$XBI $89.80 | +0.9% Pipeline Updates $RETA +2.2% Reata Pharmaceuticals Receives Complete Response Letter From The FDA for Bardoxolone...

$XBI $89.00 | +8.67% Covid Updates $TFFP TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of...

$XBI $85.10 | -4.04% Covid Updates $NVAX -7.4% Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States....

$XBI $88.68 | -0.79% Covid Updates $SRNE -2.5% Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron...

BULL THESIS BLU overall corporate and executive summary ~$380M in cash (including $150M offering about to close) Yrs of cash Should cover...

$XBI $89.39 | -1.35% Pipeline Updates $CDAK -5.0% Data from Codiak’s exoASO™-STAT6 Preclinical Development Program for the Treatment of...

As we reach the middle of the month, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly...

$XBI $90.61 | -4.3% Covid Updates $NVAX -3.6% Health Canada Authorizes Novavax COVID-19 Vaccine source Pipeline Updates $AGIO -5.2%...

$XBI $94.65 | -1.04% Covid Updates $ENTA -2.1% Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-235, its...

$XBI $95.64 | +4.2% Covid Updates $BNTX +5.8% BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference...

$XBI $91.81 | -1.7% Covid Updates $NVAX -11.4% Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland....

$XBI $93.35 | 1% Covid Updates $GILD Phase 2/3 Interim Data Evaluating the Safety, Tolerability and Clinical Outcomes of Veklury®...

As February begins, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD...